Cytek share price

WebApr 12, 2024 · CTKB Cytek Biosciences, Inc. Stock Price & Overview 454 followers $8.98 0.31 ( +3.58%) 4:00 PM 04/06/23 NASDAQ $USD Post-Market: $8.98 4:12 PM … WebApr 11, 2024 · The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share. Cytek Biosciences Inc Stock Price History. Cytek Biosciences Inc’s price is currently up 3.92% so far this month. During the month of April, Cytek Biosciences Inc’s stock price has reached a high of ...

Government Scientific Source

WebApr 6, 2024 · Cytokinetics started at overweight with $58 stock price target at J.P. Morgan. Dec. 10, 2024 at 6:59 a.m. ET by Tomi Kilgore. Biotech and Pharma Cytokinetics Stock … WebMar 9, 2024 · As of March 9, 2024, Cytek Biosciences Inc’s stock price is $9.38, which is down 4.58% from its previous closing price. At AAII, we stress that investors should … how many months from 06/01/2021 to 1/1/23 https://mgcidaho.com

CTKB - Cytek Biosciences Inc Stock Price Quote - NASDAQ

WebApr 9, 2024 · CYTEC INDUSTRIES INC (NYSE:) : Stock quote, stock chart, quotes, analysis, advice, financials and news for share CYTEC INDUSTRIES INC Nyse: Nyse … WebApr 11, 2024 · As of April 11, 2024, Cytek Biosciences Inc’s stock price is $9.55, which is up 6.35% from its previous closing price. At AAII, we stress that investors should never … WebApr 11, 2024 · The Zacks Consensus Estimate for Encompass Health’s 2024 earnings is pegged at $3.07 per share, indicating a 7.7% increase from the prior-year reported figure. ... Cytek Biosciences, Inc ... how bad is a tarantula bite

Cytek Biosciences, Inc. Common Stock (CTKB) Stock Price, Quote, …

Category:Why Cytek Biosciences Inc’s (CTKB) Stock Is Up 6.35% AAII

Tags:Cytek share price

Cytek share price

Cytek Company Profile: Stock Performance & Earnings PitchBook

WebView the latest Cytek Biosciences Inc. (CTKB) stock price, news, historical charts, analyst ratings and financial information from WSJ. CTKB Cytek Biosciences Inc. Stock Price … WebApr 11, 2024 · 3 equities research analysts have issued 1 year price objectives for Cytek Biosciences' stock. Their CTKB share price forecasts range from $14.00 to $15.00. On …

Cytek share price

Did you know?

Web17 hours ago · Price To Free Cash Flow is a widely used stock evaluation measure. Find the latest Price To Free Cash Flow for Cytek Biosciences (CTKB) WebJul 19, 2024 · Cytek Biosciences, Inc. Common Stock (CTKB) Stock Price, Quote, News & History Nasdaq Cytek Biosciences, Inc. Common Stock (CTKB) Add to Watchlist Add …

WebApr 11, 2024 · With Cytek Biosciences stock trading at $11.78 per share, the total value of Cytek Biosciences stock (market capitalization) is $1.59B. Cytek Biosciences stock was … WebApr 5, 2024 · Price *Price Target Lowest: 11.00 Median: 17.00 Highest: 28.00 *The average price target includes all analyst analysis, not just the most recent analysis presented in …

WebCytek Biosciences is registered under the ticker NASDAQ:CTKB . Their stock opened with $17.00 in its Jul 23, 2024 IPO. Stock Symbol NASDAQ:CTKB Valuation at IPO $2.2B … WebMar 23, 2024 · Cytek was founded as Cytoville in 2014 and went public in July 2024, raising net proceeds of $215.7 million at $17 per share. Its stock trades just over $11.00 a share, translating to a market cap ...

WebFeb 28, 2024 · Cytek Biosciences, Inc. provided revenue guidance for the full year 2024. For the year, the company expects revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This includes approximately $20 million of revenue contribution from the acquisition of Luminex's Flow Cytometry and …

WebCytek Biosciences, Inc. (CTKB) Stock Price, News, Quote & History - Yahoo Finance U.S. markets closed S&P 500 Dow 30 +415.15 Nasdaq +208.41(+1.73%) Russell 2000 … Find out all the key statistics for Cytek Biosciences, Inc. (CTKB), including … Interactive Chart for Cytek Biosciences, Inc. (CTKB), analyze all the data with a huge … Find the latest Cytek Biosciences, Inc. (CTKB) stock discussion in Yahoo … Discover historical prices for CTKB stock on Yahoo Finance. View daily, weekly or … See Cytek Biosciences, Inc. (CTKB) stock analyst estimates, including earnings … Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, … View the basic CTKB option chain and compare options of Cytek Biosciences, … Get the detailed quarterly/annual income statement for Cytek Biosciences, Inc. … Find out the direct holders, institutional holders and mutual fund holders for … Get the latest Cytek Biosciences, Inc. (CTKB) stock news and headlines to … how bad is a valve cover leakWebApr 10, 2024 · In 2024, CTKB's revenue was $164.04 million, an increase of 28.20% compared to the previous year's $127.95 million. Earnings were $2.58 million, a decrease of -14.16%. Financial Statements. how many months elephant pregnantWebOct 14, 2024 · Hence, if weakness in Cytek Biosciences' share price continues, institutional investors may feel compelled to sell the stock, which might not be ideal for individual investors. how bad is bang energyWebFeb 17, 2024 · As of Tuesday, February 14, Cytek Biosciences Inc’s CTKB share price has dipped by 8.77%, which has investors questioning if this is right time to buy. Jenna Brashear. Stock Grade Focus Is Cytek Biosciences Inc (CTKB) Stock a Good Investment? Learn more about Cytek Biosciences Inc's (CTKB) stock grades for Value, Momentum, … how bad is a virus pcWeb1. Enter the amount you'd like to invest in Cytek Biosciences Inc stock, then proceed to checkout. Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive. Cytek Biosciences Inc ’s share price is determined by its bid-ask ... how many months do you carry a baby full termWebCTKB Complete Cytek Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. how bad is a torn achillesWebJul 21, 2024 · Using relative valuation and targeting the maximum offering's share price of $18, I conclude that Cytek Biosciences' high multiples are justified by the company's … how bad is avian flu